HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lurtotecan

NX-211 is the low-clearance liposomal formulation; structure in first source
Also Known As:
7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(S)-camptothecin; GG-211; GG211; GI 147211; GI-147211; GI147211; Gl 147211C; Gl-147211C; Gl147211C; NX 211; NX-211; NX211 cpd; OSI 211; OSI-211; OSI211
Networked: 20 relevant articles (3 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hamilton, Marta: 3 articles (03/2005 - 03/2002)
2. Barrett, Emma: 3 articles (03/2005 - 04/2004)
3. Ptaszynski, M: 3 articles (08/2004 - 03/2001)
4. Hamilton, M: 3 articles (08/2004 - 07/2000)
5. Cameron, Terri: 2 articles (03/2005 - 03/2002)
6. Gelmon, K: 2 articles (08/2004 - 04/2004)
7. Fisher, B: 2 articles (08/2004 - 04/2004)
8. Eisenhauer, E: 2 articles (08/2004 - 04/2004)
9. Giles, Francis J: 2 articles (04/2004 - 11/2003)
10. Richardson, F C: 2 articles (03/2001 - 07/2000)

Related Diseases

1. Neoplasms (Cancer)
2. Ovarian Neoplasms (Ovarian Cancer)
3. Hematologic Neoplasms (Hematological Malignancy)
4. Thrombocytopenia (Thrombopenia)
5. Neutropenia

Related Drugs and Biologics

1. lurtotecan
2. Type I DNA Topoisomerases (Topoisomerase I)
3. Topotecan (Hycamtin)
4. 9-amino-20-camptothecin
5. Camptothecin
6. Cisplatin (Platino)
7. Topoisomerase I Inhibitors
8. Fibroblast Growth Factor 7
9. Brain Natriuretic Peptide (Natrecor)
10. Nelfinavir (Viracept)

Related Therapies and Procedures

1. Intravenous Infusions
2. Heterologous Transplantation (Xenotransplantation)
3. Stents